Washington Journal
Representatives Gingrey and Green on ADAPT Legislation
2014-09-19T07:49:53-04:00https://ximage.c-spanvideo.org/eyJidWNrZXQiOiJwaWN0dXJlcy5jLXNwYW52aWRlby5vcmciLCJrZXkiOiJGaWxlc1wvOWIxXC8yMDE0MDkxOTA4MDQwNjAwMV9oZC5qcGciLCJlZGl0cyI6eyJyZXNpemUiOnsiZml0IjoiY292ZXIiLCJoZWlnaHQiOjUwNn19fQ==Representatives Phil Gingrey (R-GA) and Gene Green (D-TX) talked about their bipartisan legislation, the Antibiotic Development to Advance Patient Treatment (ADAPT) Act of 2013, that would accelerate development of new antibiotics to fight drug-resistant diseases by streamlining the Food and Drug Administration approval process while boosting the Centers for Disease Control’s monitoring efforts. They also talked about Congress recessing earlier than usual for re-election campaigning and what work would be done after the midterm elections. Other topics included the legislation passed that week to aid Syrian rebels.
Representatives Phil Gingrey (R-GA) and Gene Green (D-TX) talked about their bipartisan legislation, the Antibiotic Development to Advance…
read more
Representatives Phil Gingrey (R-GA) and Gene Green (D-TX) talked about their bipartisan legislation, the Antibiotic Development to Advance Patient Treatment (ADAPT) Act of 2013, that would accelerate development of new antibiotics to fight drug-resistant diseases by streamlining the Food and Drug Administration approval process while boosting the Centers for Disease Control’s monitoring efforts. They also talked about Congress recessing earlier than usual for re-election campaigning and what work would be done after the midterm elections. Other topics included the legislation passed that week to aid Syrian rebels. close
Representatives Phil Gingrey (R-GA) and Gene Green (D-TX) talked about their bipartisan legislation, the Antibiotic Development to Advance… read more
Representatives Phil Gingrey (R-GA) and Gene Green (D-TX) talked about their bipartisan legislation, the Antibiotic Development to Advance Patient Treatment (ADAPT) Act of 2013, that would accelerate development of new antibiotics to fight drug-resistant diseases by streamlining the Food and Drug Administration approval process while boosting the Centers for Disease Control’s monitoring efforts. They also talked about Congress recessing earlier than usual for re-election campaigning and what work would be done after the midterm elections. Other topics included the legislation passed that week to aid Syrian rebels. close
People in this video
More PeopleHosting Organization
Series
More Videos From
Washington Journal 09/19/2014
More VideosRelated Video
-
Antibiotic Resistance and Drug Development
Dr. Janet Woodcock testified at a House Energy and Commerce subcommittee hearing on combating antibiotic resistance and…
-
A Mere Machine
Professor Anna Harvey talked about her book, A Mere Machine: The Supreme Court, Congress, and American Democracy in which she…
-
Open Phones
Telephone lines were open for viewer comments on U.S. response to the Ebola virus disease. Abby Phillip also spoke by phone…
-
Congressional Investigation of U.S. Ebola Response
Representative Gene Green (R-TX), a member of the House Energy and Commerce Committee, previewed a subcommittee hearing on…